<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology and pathophysiology of diphtheria</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology and pathophysiology of diphtheria</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology and pathophysiology of diphtheria</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Luis F Barroso, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">P Samuel Pegram, MD, FACP</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer Mitty, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Diphtheria is an infectious disease caused by the gram-positive bacillus <em>Corynebacterium diphtheriae</em>. Infection may lead to respiratory disease, cutaneous disease, or an asymptomatic carrier state. The word diphtheria comes from the Greek word for leather, which refers to the tough pharyngeal membrane that is the clinical hallmark of infection. Rarely, a similar disease can be caused by other <em>Corynebacterium</em> species: <em>C. ulcerans</em>, <em>C. hemolyticum</em>, and <em>C. pseudotuberculosis </em>[<a href="#rid1">1</a>].</p><p>The epidemiology and pathophysiology of diphtheria will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8047.html" rel="external">"Clinical manifestations, diagnosis, and treatment of diphtheria"</a> and  <a class="medical medical_review" href="/z/d/html/3897.html" rel="external">"Tetanus-diphtheria toxoid vaccination in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2838.html" rel="external">"Diphtheria, tetanus, and pertussis immunization in children 7 through 18 years of age"</a> and  <a class="medical medical_review" href="/z/d/html/2844.html" rel="external">"Diphtheria, tetanus, and pertussis immunization in children 6 weeks through 6 years of age"</a>.)</p><p class="headingAnchor" id="H9250687"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H3810657879"><span class="h2">Biotypes causing disease</span><span class="headingEndMark"> — </span>There are at least four biotypes or biovars of <em>C. diphtheriae</em>: <em>gravis</em>, <em>intermedius</em>, <em>mitis</em>, and <em>belfanti</em>. All biotypes have been associated with both endemic and epidemic diphtheria. However, <em>belfanti</em> is rarely described as toxigenic, whereas the other biotypes are named for their association with disease severity: <em>gravis</em> (serious), <em>intermedius</em> (intermediate), and <em>mitis</em> (mild) [<a href="#rid1">1</a>].</p><p><em>C. ulcerans</em> is a rare cause of respiratory illness that resembles diphtheria. It has been reported predominantly in industrialized countries, which may be due in part to detection bias [<a href="#rid2">2-5</a>]. Isolated cases of diphtheria-like illness due to <em>C. ulcerans</em> were reported in the United States in 2008 and 2010 [<a href="#rid2">2,3</a>]. Like <em>C. diphtheriae</em>, <em>C. ulcerans </em>can produce diphtheria toxin and lead to life-threatening disease that requires urgent treatment with <a class="drug drug_general" data-topicid="8900" href="/z/d/drug information/8900.html" rel="external">diphtheria antitoxin</a> and macrolide antibiotics. However, unlike <em>C. diphtheriae</em>, <em>C. ulcerans</em> is a zoonotic illness; evidence for human-to-human transmission is limited.</p><p class="headingAnchor" id="H506726880"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>The primary modes of spread consist of close contact with infectious material from respiratory secretions (direct or via airborne droplet) or from skin lesions. Humans are believed to be the only known reservoir for <em>C. diphtheriae</em>, although rare cases of disease in animals have been reported [<a href="#rid6">6-9</a>]. Infection may occur throughout the year with a peak incidence in the colder months.</p><p>Asymptomatic carriers are important for transmission of diphtheria. Immunity (either via natural infection or vaccine induced) does not prevent carriage [<a href="#rid10">10,11</a>]. In areas of endemicity, up to 5 percent of healthy individuals may have positive pharyngeal cultures [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H660671484"><span class="h2">Burden of disease</span><span class="headingEndMark"> — </span>In the prevaccine era, diphtheria was a major cause of morbidity and mortality worldwide, primarily affecting children under the age of 15 [<a href="#rid13">13</a>]. Until the beginning of the 20th century, as many as 10 percent of American children developed clinical diphtheria, and a significant number died from its complications (case-fatality rate of 5 to 10 percent) [<a href="#rid14">14</a>]. By adolescence, 70 to 80 percent of the urban population was immune to diphtheria from natural infection [<a href="#rid15">15</a>].</p><p>During the 1930s and 1940s, diphtheria was virtually eliminated in many resource-rich countries following the introduction of routine childhood vaccination with diphtheria toxoid. As a result of vaccination, toxigenic strains of <em>C. diphtheriae</em> lose the selective advantage conferred by the <em>tox+</em> gene and are less prevalent [<a href="#rid16">16</a>]; the worldwide incidence has fallen from about 100,000 per year to less than 8000 per year (although many cases may go unreported). Worldwide, the vaccination rate is &gt;80 percent; outbreaks of diphtheria may occur when the density of unvaccinated individuals in one or more locations increases and herd immunity declines, as occurred in the former Soviet Union in the 1990s [<a href="#rid17">17,18</a>].</p><p>As the general population becomes immune, there are fewer cases of clinical diphtheria (from toxigenic strains) and less asymptomatic colonization with toxigenic strains and therefore decreased transmission to nonimmune people. However, there does not appear to be any reduction in the prevalence of carriers of nontoxigenic <em>C. diphtheriae</em> [<a href="#rid19">19</a>]. Immunized individuals can develop clinical diphtheria, although disease is less severe and occurs less frequently.</p><p>Diphtheria is reappearing in some regions. In countries experiencing a resurgence of diphtheria, epidemics have involved children as well as insufficiently immunized adults [<a href="#rid20">20-22</a>]. As an example, due to declining vaccine coverages, confirmed diphtheria outbreaks have occurred in Brazil (11 suspected cases in the first half of 2021, 59 probable cases between 2019 and 2020) and the Dominican Republic (35 probable cases in the first half of 2021) [<a href="#rid23">23</a>]. In Haiti, there were 1281 suspected cases between 2014 and 2021, and the Pan American Health Organization considers the disease endemic in that country.</p><p class="headingAnchor" id="H9250694"><span class="h3">Resource-rich countries</span><span class="headingEndMark"> — </span>Since the availability of vaccination, diphtheria has remained rare in resource-rich countries. However, approximately 20 to 60 percent of adults are susceptible to diphtheria because of waning vaccine-induced immunity and failure to receive booster immunization [<a href="#rid24">24-26</a>]. Among 1000 British adults who underwent evaluation of serum <a class="drug drug_general" data-topicid="8900" href="/z/d/drug information/8900.html" rel="external">diphtheria antitoxin</a> titers, 38 percent were susceptible to diphtheria (serum diphtheria antitoxin concentration below 0.01 international units/mL); 31 percent had basic protection; and only 31 percent were fully protected [<a href="#rid24">24</a>]. Similarly, in a large United States serologic survey, immunity among adults over the age of 60 years was 30 percent; immunity among children between the ages of 6 and 11 years was 91 percent [<a href="#rid26">26</a>]. The United States Centers for Disease Control and Prevention (CDC) recommends that adults receive a diphtheria-toxoid–containing vaccine (Tdap or Td as indicated) every 10 years after completing a primary childhood vaccination series [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/z/d/html/3897.html" rel="external">"Tetanus-diphtheria toxoid vaccination in adults"</a>.)</p><p>Despite incomplete immunity, the rate of clinical disease is low, in part because immunization has minimized the transmission of toxigenic strains [<a href="#rid28">28</a>]. As an example, the last major United States outbreak of diphtheria occurred in Seattle in the 1970s [<a href="#rid29">29</a>]. However, the disease continues to cause illness globally, and sporadic, imported cases can rarely occur in the United States. Between 2015 and 2018, four cases of cutaneous diphtheria due to toxigenic strains were reported by the CDC, all in travelers returning from countries where diphtheria is endemic [<a href="#rid30">30</a>]. If toxigenic strains became widely disseminated again, the incidence could increase. </p><p>Spain has a high immunization rate; it reported its first case of diphtheria since 1986 in May 2015 in an unvaccinated six-year-old boy; the patient died but eight close contacts with colonization were isolated and treated successfully [<a href="#rid31">31</a>]. Previous vaccination likely protected the contacts from clinical disease [<a href="#rid32">32</a>].</p><p>An epidemic of diphtheria spread throughout the newly independent states (NIS) of the former Soviet Union in the 1990s [<a href="#rid17">17</a>]. Between 1990 and 1998, more than 80 percent of all cases of diphtheria in the world were reported from the former Soviet Union; more than 157,000 cases were registered with the WHO from NIS, with 5000 deaths [<a href="#rid33">33</a>]. Factors contributing to the spread of the epidemic included shortages of antibiotics, antitoxin, and vaccine (resulting in the presence of a susceptible child and adult population), socioeconomic instability, population movement, and a deteriorating health infrastructure.</p><p>Several other European countries have experienced outbreaks, often characterized by high case fatality rates, a large proportion of patients with complications, and a high percentage of cases in adults [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H9250701"><span class="h3">Resource-limited countries</span><span class="headingEndMark"> — </span>Diphtheria remains a serious disease throughout much of the world. Areas of endemicity include Africa (Algeria, Egypt, and countries in the sub-Saharan region), the Americas (Brazil, Colombia, the Dominican Republic, Ecuador, Haiti, and Paraguay), Asia (Afghanistan, Bangladesh, Bhutan, Cambodia, China, India, Indonesia, Laos, Mongolia, Burma [Myanmar], Nepal, Pakistan, Papua New Guinea, the Philippines, Thailand, and Vietnam), the Middle East (Iran, Iraq, Syria, and Yemen), and Europe (Turkey, Albania, and all countries of the former Soviet Union) [<a href="#rid35">35,36</a>].</p><p>Close contacts of unvaccinated or inadequately vaccinated travelers to endemic areas are also at risk for infection. For example, a case of respiratory diphtheria was reported in 2004 in a 60-year-old Haitian-born Massachusetts resident with unknown vaccination status against diphtheria with no recent travel [<a href="#rid37">37</a>]. The patient presented with fever and respiratory symptoms and was misdiagnosed with streptococcal pharyngitis based on a rapid antigen test. The throat culture yielded toxigenic <em>C. diphtheriae</em>. Her asymptomatic spouse also had a throat culture positive for toxigenic diphtheria and, two months earlier, had traveled to an area of Haiti where cases of diphtheria had been reported.</p><p>Re-emergence of diphtheria has occurred among populations in Burma (Myanmar) [<a href="#rid38">38</a>], Yemen [<a href="#rid39">39</a>], and Venezuela [<a href="#rid40">40</a>] impacted by the collapse of health care systems, limited access to vaccinations and medications, and an exodus of health care workers. They have exported diphtheria to neighboring countries (Rohingya to Bangladesh, Yemeni to countries in the Horn of Africa, and Venezuelans to other Latin American countries). Clinicians should maintain an appropriately high index of suspicion for diphtheria among migrant and displaced populations who may be suffering from lack of access to health care and vaccination, as well as exposure to conditions that facilitate spread of the disease.</p><p class="headingAnchor" id="H2"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Symptomatic diphtherial infection results from localized inflammation of the respiratory tract or skin as well as local and systemic effects of a potent diphtheria exotoxin.</p><p>Exotoxin production depends on the presence of a lysogenic bacteriophage that carries the gene encoding for toxin (<em>tox+</em>) [<a href="#rid41">41,42</a>]. The toxin has a total of three domains. One domain is present in fragment A (the catalytic unit), and the remaining two domains are in fragment B (one for receptor binding and one that may participate in membrane insertion and translocation) [<a href="#rid43">43</a>].</p><p>Diphtheria toxin acts inside the cells, where it causes cell death by inactivating elongation factor 2 [<a href="#rid44">44</a>]. The toxin binds to a membrane receptor providing a mechanism of cell entry [<a href="#rid44">44,45</a>]. Diphtheria toxin exploits a growth factor precursor as a receptor: diphtheria toxin receptor appears to be identical to the precursor of a heparin-binding epidermal growth factor-like growth factor [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H4154543"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Diphtheria is an infectious disease caused by the gram-positive bacillus <em>Corynebacterium diphtheriae</em>. Infection may lead to respiratory disease, cutaneous disease, or an asymptomatic carrier state. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> – The primary modes of spread consist of close contact with infectious material from respiratory secretions (direct or via airborne droplet) or from skin lesions. Infection occurs throughout the year with a peak incidence in the colder months. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1">Humans are the only known reservoir f<em>or C. diphtheriae</em>. Therefore, asymptomatic carriers are important in diphtheria transmission. Immunity (either via natural infection or vaccine induced) does not prevent carriage. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Burden of disease</strong> – In areas of endemicity, up to 5 percent of healthy individuals may have positive pharyngeal cultures. Immunization has minimized the transmission of toxigenic strains; diphtheria is rare in resource-rich settings, although sporadic cases continue to occur. (See <a class="local">'Burden of disease'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sharma NC, Efstratiou A, Mokrousov I, et al. Diphtheria. Nat Rev Dis Primers 2019; 5:81.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Notes from the field: respiratory diphtheria-like illness caused by toxigenic Corynebacterium ulcerans --- Idaho, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:77.</a></li><li><a class="nounderline abstract_t">Tiwari TS, Golaz A, Yu DT, et al. Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis 2008; 46:395.</a></li><li><a class="nounderline abstract_t">Taylor J, Saveedra-Campos M, Harwood D, et al. Toxigenic Corynebacterium ulcerans infection in a veterinary student in London, United Kingdom, May 2010. Euro Surveill 2010; 15.</a></li><li><a class="nounderline abstract_t">Wagner KS, White JM, Crowcroft NS, et al. Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect 2010; 138:1519.</a></li><li><a class="nounderline abstract_t">Bostock AD, Gilbert FR, Lewis D, Smith DC. Corynebacterium ulcerans infection associated with untreated milk. J Infect 1984; 9:286.</a></li><li class="breakAll">Rosenau MJ. Diseases spread by milk. In: Preventive Medicine and Hygiene, 5th Ed, Appleton, New York 1928. p.718.</li><li><a class="nounderline abstract_t">Hall AJ, Cassiday PK, Bernard KA, et al. Novel Corynebacterium diphtheriae in domestic cats. Emerg Infect Dis 2010; 16:688.</a></li><li><a class="nounderline abstract_t">Henricson B, Segarra M, Garvin J, et al. Toxigenic Corynebacterium diphtheriae associated with an equine wound infection. J Vet Diagn Invest 2000; 12:253.</a></li><li><a class="nounderline abstract_t">Doull JA, Lara H. The epidemiologic importance of diphtheria carriers. Am J Hyg 1925; 5:508.</a></li><li><a class="nounderline abstract_t">Miller LW, Older JJ, Drake J, Zimmerman S. Diphtheria immunization. Effect upon carriers and the control of outbreaks. Am J Dis Child 1972; 123:197.</a></li><li><a class="nounderline abstract_t">Kalapothaki V, Sapounas T, Xirouchaki E, et al. Prevalence of diphtheria carriers in a population with disappearing clinical diphtheria. Infection 1984; 12:387.</a></li><li><a class="nounderline abstract_t">English PC. Diphtheria and theories of infectious disease: centennial appreciation of the critical role of diphtheria in the history of medicine. Pediatrics 1985; 76:1.</a></li><li><a class="nounderline abstract_t">Frost WH. Infection, immunity and disease in the epidemiology of diphtheria, with special reference to some studies in Baltimore. J Prev Med 1928; 2:325.</a></li><li><a class="nounderline abstract_t">Zingher A. The Schick test performed on more than 150,000 children in public and parochial schools in New York (Manhattan and the Bronx). Am J Dis Child 1923; 25:392.</a></li><li class="breakAll">Pappenheimer AM. Diphtheria: Studies on the biology of an infectious disease. In: The Harvey Lectures, Series 76, Academic Press, New York 1980-81. p.45.</li><li><a class="nounderline abstract_t">Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis 1998; 4:539.</a></li><li class="breakAll">World Health Organization. Immunization, Vaccines and Biologicals: Diptheria. http://www.who.int/immunization/monitoring_surveillance/burden/diphtheria/en/ (Accessed on February 22, 2016).</li><li><a class="nounderline abstract_t">Wilson AP. The return of Corynebacterium diphtheriae: the rise of non-toxigenic strains. J Hosp Infect 1995; 30 Suppl:306.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Diphtheria outbreak--Saraburi Province, Thailand, 1994. MMWR Morb Mortal Wkly Rep 1996; 45:271.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Diphtheria epidemic--New Independent States of the former Soviet Union, 1990-1994. MMWR Morb Mortal Wkly Rep 1995; 44:177.</a></li><li><a class="nounderline abstract_t">Kitamura N, Hoan TT, Do HM, et al. Seroepidemiology and Carriage of Diphtheria in Epidemic-Prone Area and Implications for Vaccination Policy, Vietnam. Emerg Infect Dis 2023; 29:70.</a></li><li class="breakAll">Epidemiological Alert: Diphtheria - 25 June 2021. Pan American Health Organization/World Health Organization. Available at: https://www.paho.org/en/documents/epidemiological-alert-diphtheria-25-june-2021. (Accessed on February 07, 2022).</li><li><a class="nounderline abstract_t">Maple PA, Efstratiou A, George RC, et al. Diphtheria immunity in UK blood donors. Lancet 1995; 345:963.</a></li><li><a class="nounderline abstract_t">Weiss BP, Strassburg MA, Feeley JC. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health 1983; 73:802.</a></li><li><a class="nounderline abstract_t">McQuillan GM, Kruszon-Moran D, Deforest A, et al. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002; 136:660.</a></li><li><a class="nounderline abstract_t">Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2010. Ann Intern Med 2010; 152:36.</a></li><li><a class="nounderline abstract_t">Truelove SA, Keegan LT, Moss WJ, et al. Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis. Clin Infect Dis 2020; 71:89.</a></li><li><a class="nounderline abstract_t">Coyle MB, Groman NB, Russell JQ, et al. The molecular epidemiology of three biotypes of Corynebacterium diphtheriae in the Seattle outbreak, 1972-1982. J Infect Dis 1989; 159:670.</a></li><li><a class="nounderline abstract_t">Griffith J, Bozio CH, Poel AJ, et al. Imported Toxin-Producing Cutaneous Diphtheria - Minnesota, Washington, and New Mexico, 2015-2018. MMWR Morb Mortal Wkly Rep 2019; 68:281.</a></li><li class="breakAll">World Health Organization. Diphtheria detected in Spain. http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/news/news/2015/06/diphtheria-detected-in-spain (Accessed on February 22, 2016).</li><li class="breakAll">European Centre for Disease Prevention and Control. Rapid Risk Assessment: A case of diptheria in Spain, 15 June 2015. http://ecdc.europa.eu/en/publications/Publications/diphtheria-spain-rapid-risk-assessment-june-2015.pdf (Accessed on February 22, 2016).</li><li><a class="nounderline abstract_t">Dittmann S, Wharton M, Vitek C, et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000; 181 Suppl 1:S10.</a></li><li><a class="nounderline abstract_t">Galazka AM, Robertson SE. Diphtheria: changing patterns in the developing world and the industrialized world. Eur J Epidemiol 1995; 11:107.</a></li><li><a class="nounderline abstract_t">Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol 1995; 11:95.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Fatal respiratory diphtheria in a U.S. traveler to Haiti--Pennsylvania, 2003. MMWR Morb Mortal Wkly Rep 2004; 52:1285.</a></li><li class="breakAll">Bureau of Communicable Disease Control. Toxigenic diphtheria cultured from a patient with respiratory symptoms. Department of Public Health, The Commonwealth of Massachusetts, 2004.</li><li class="breakAll">World Health Organization. Emergency type: Rohingya Refugee Crisis. www.searo.who.int/bangladesh/weeklysitrep42cxbban.pdf (Accessed on January 28, 2019).</li><li><a class="nounderline abstract_t">Dureab F, Müller O, Jahn A. Resurgence of diphtheria in Yemen due to population movement. J Travel Med 2018; 25.</a></li><li><a class="nounderline abstract_t">Tuite AR, Thomas-Bachli A, Acosta H, et al. Infectious disease implications of large-scale migration of Venezuelan nationals. J Travel Med 2018; 25.</a></li><li><a class="nounderline abstract_t">FREEMAN VJ. Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae. J Bacteriol 1951; 61:675.</a></li><li><a class="nounderline abstract_t">Nakao H, Pruckler JM, Mazurova IK, et al. Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol 1996; 34:1711.</a></li><li><a class="nounderline abstract_t">Choe S, Bennett MJ, Fujii G, et al. The crystal structure of diphtheria toxin. Nature 1992; 357:216.</a></li><li><a class="nounderline abstract_t">Naglich JG, Rolf JM, Eidels L. Expression of functional diphtheria toxin receptors on highly toxin-sensitive mouse cells that specifically bind radioiodinated toxin. Proc Natl Acad Sci U S A 1992; 89:2170.</a></li><li><a class="nounderline abstract_t">Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69:1051.</a></li></ol></div><div id="topicVersionRevision">Topic 8051 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31804499" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diphtheria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21270746" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Notes from the field: respiratory diphtheria-like illness caused by toxigenic Corynebacterium ulcerans --- Idaho, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18181738" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20738991" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Toxigenic Corynebacterium ulcerans infection in a veterinary student in London, United Kingdom, May 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20696088" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6527044" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Corynebacterium ulcerans infection associated with untreated milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6527044" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Corynebacterium ulcerans infection associated with untreated milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20350389" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Novel Corynebacterium diphtheriae in domestic cats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10826839" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Toxigenic Corynebacterium diphtheriae associated with an equine wound infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The epidemiologic importance of diphtheria carriers</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5026197" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Diphtheria immunization. Effect upon carriers and the control of outbreaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6519811" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prevalence of diphtheria carriers in a population with disappearing clinical diphtheria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3892472" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Diphtheria and theories of infectious disease: centennial appreciation of the critical role of diphtheria in the history of medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Infection, immunity and disease in the epidemiology of diphtheria, with special reference to some studies in Baltimore</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The Schick test performed on more than 150,000 children in public and parochial schools in New York (Manhattan and the Bronx)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The Schick test performed on more than 150,000 children in public and parochial schools in New York (Manhattan and the Bronx)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9866730" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Diphtheria in the former Soviet Union: reemergence of a pandemic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9866730" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Diphtheria in the former Soviet Union: reemergence of a pandemic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7560966" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The return of Corynebacterium diphtheriae: the rise of non-toxigenic strains.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8596528" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Diphtheria outbreak--Saraburi Province, Thailand, 1994.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7870021" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Diphtheria epidemic--New Independent States of the former Soviet Union, 1990-1994.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36573549" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Seroepidemiology and Carriage of Diphtheria in Epidemic-Prone Area and Implications for Vaccination Policy, Vietnam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36573549" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Seroepidemiology and Carriage of Diphtheria in Epidemic-Prone Area and Implications for Vaccination Policy, Vietnam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7715300" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Diphtheria immunity in UK blood donors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6859366" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Tetanus and diphtheria immunity in an elderly population in Los Angeles County.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11992301" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Serologic immunity to diphtheria and tetanus in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20048270" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Recommended adult immunization schedule: United States, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31425581" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2494266" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The molecular epidemiology of three biotypes of Corynebacterium diphtheriae in the Seattle outbreak, 1972-1982.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30921303" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Imported Toxin-Producing Cutaneous Diphtheria - Minnesota, Washington, and New Mexico, 2015-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30921303" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Imported Toxin-Producing Cutaneous Diphtheria - Minnesota, Washington, and New Mexico, 2015-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30921303" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Imported Toxin-Producing Cutaneous Diphtheria - Minnesota, Washington, and New Mexico, 2015-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10657185" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7489768" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Diphtheria: changing patterns in the developing world and the industrialized world.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7489783" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Resurgence of diphtheria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14712177" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Fatal respiratory diphtheria in a U.S. traveler to Haiti--Pennsylvania, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14712177" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Fatal respiratory diphtheria in a U.S. traveler to Haiti--Pennsylvania, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14712177" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Fatal respiratory diphtheria in a U.S. traveler to Haiti--Pennsylvania, 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30289480" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Resurgence of diphtheria in Yemen due to population movement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30192972" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Infectious disease implications of large-scale migration of Venezuelan nationals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14850426" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Studies on the virulence of bacteriophage-infected strains of Corynebacterium diphtheriae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8784575" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1589020" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The crystal structure of diphtheria toxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1549577" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Expression of functional diphtheria toxin receptors on highly toxin-sensitive mouse cells that specifically bind radioiodinated toxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1606612" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
